Authors: Vogel, CL

Citation: Cl. Vogel, Systemic therapy for older women with breast cancer - The Kimmick/Muss article reviewed, ONCOLOGY-NY, 15(3), 2001, pp. 295

Authors: Perez, EA Vogel, CL Irwin, DH Kirshner, JJ Patel, R

Citation: Ea. Perez et al., Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer, J CL ONCOL, 19(22), 2001, pp. 4216-4223

Authors: Vogel, CL Cobleigh, MA Tripathy, D Gutheil, JC Harris, LN Fehrenbacher, L Slamon, DJ Murphy, M Novotny, WF Burchmore, M Shak, S Stewart, SJ

Citation: Cl. Vogel et al., First-line Herceptin (R) monotherapy in metastatic breast cancer, ONCOL-BASEL, 61, 2001, pp. 37-42

Authors: Cobleigh, MA Vogel, CL Tripathy, D Robert, NJ Scholl, S Fehrenbacher, L Wolter, JM Paton, V Shak, S Lieberman, G Slamon, DJ

Citation: Ma. Cobleigh et al., Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease, J CL ONCOL, 17(9), 1999, pp. 2639-2648

Authors: Buzdar, AU Jonat, W Howell, A Jones, SE Blomqvist, CP Vogel, CL

Citation: Au. Buzdar et al., Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on acombined analysis of data from two mature phase III trials (vol 83, pg 1142, 1998), CANCER, 85(4), 1999, pp. 1010-1010